Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|November 6, 2018
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified ChemoradiotherapyKevin A Pearlstein, Kyle Wang, Robert J Amdur, et al.The Oncologist|May 10, 2022
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland CancersXiuning Le, Christina Baik, Jessica Bauman, et al.British Journal of Cancer|May 3, 2017
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignanciesRastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, et al.Lung Cancer (Amsterdam, Netherlands)|September 17, 2014
Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinomaNi Zhao, Matthew D Wilkerson, Usman Shah, et al.JCO Precision Oncology|September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable PhenotypeJordan Kardos, Sara E Wobker, Michael E Woods, et al.Journal for Immunotherapy of Cancer|August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobert L Ferris, Rom S Leidner, Christine H Chung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.Journal for Immunotherapy of Cancer|June 29, 2023
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomasAndrew L Coveler, David C Smith, Tycel Phillips, et al.The Oncologist|November 22, 2017
Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive ComputingNirali M Patel, Vanessa V Michelini, Jeff M Snell, et al.Pageof 5